Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juni 2024

Genmab — Juni 2024

Planlagt Fastgjort Låst Flyttet Genmab
946 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #706

    Ja der er vist ikke noget at stimulere hvis ikke PD-L1 blokeres

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #707

      recent interview with Jan van de Winkel of
      @Genmab
      at the Royalty Pharma ABI '24 meeting https://x.com/ideapharma/status/1803822877600256329

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #708

        i can't help it, but i continue to find the man very impressive. I see an extremely confident but calm and well spoken CEO who knows exactly what he is talking
        about with a clear vision of how he thinks this company can prosper.

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #709

          Er der nogen som har link til Gen1046 præsentationen fra SITC 2019 ?

          1 Reply Last reply
          0
          • L Offline
            L Offline
            lahn1
            wrote on sidst redigeret af
            #710

            EL, thx I found my self smiling when watching that video. Agree very impressive. Think I better understand "the best is yet to come"

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #711

              Tak for korrektionen omkring virkemekanismen. Mener at have hørt det andet på et webcast. Men det gør jo, at jeg kan blive mere optimistisk omkring et evt. fistline forsøg 🙂

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #712

                Imponerende at høre Winkel og bl.a. omkring den hurtige udvikling af epco fra deres laboratorie til markedsføring.

                1 Reply Last reply
                0
                • JørgenVarnæsJ Offline
                  JørgenVarnæsJ Offline
                  JørgenVarnæs
                  wrote on sidst redigeret af
                  #713

                  For dem, der gerne vil se, hvordan overliggeren befinder sig i nsclc first line - https://ascopubs.org/doi/10.1200/JCO.21.01497

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #714

                    5 år Solsen så ved man et eller andet 😉

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #715

                      Tak Varnæs, så har vi noget at sigte efter, men Gen1046 forbliver j nok et combo middel.

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        lahn1
                        wrote on sidst redigeret af
                        #716

                        Så er SEB ude med dækning af gmab. BUY TP 2185. Så er der lidt læsestof til weekenden.

                        1 Reply Last reply
                        0
                        • JørgenVarnæsJ Offline
                          JørgenVarnæsJ Offline
                          JørgenVarnæs
                          wrote on sidst redigeret af
                          #717

                          …men derfor kan Acasunlimab jo stadig komme i first line. Sjovt som ORR stiger - men OS i first line er ikke markant anderledes end OS i second line…

                          1 Reply Last reply
                          0
                          • JørgenVarnæsJ Offline
                            JørgenVarnæsJ Offline
                            JørgenVarnæs
                            wrote on sidst redigeret af
                            #718

                            Det bliver super interessant at følge OS data efter din trøffel-gris action ifht protokollen

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #719

                              Lahn , i think the original link does not work anymore, it is in this list, p609 i believe, maybe you can search from there https://sitc.sitcancer.org/2019/abstracts/titles/index.php?filter=4-1bb

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                lahn1
                                wrote on sidst redigeret af
                                #720

                                Thx, found it on pubmed by title https://pubmed.ncbi.nlm .nih.gov/37259060/

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #721

                                  Link Preview Image
                                  An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity - PubMed

                                  We generated an Fc-muted anti-PD-L1x4-1BB BsAb, HK010, with a distinguished structural interaction with PD-L1 and 4-1BB that exhibits a synergistic antitumor effect by blocking the PD-1/PD-L1 signaling pathway and stimulating the 4-1BB signaling pathway simultaneously. It is strictly dependent on th …

                                  favicon

                                  PubMed (pubmed.ncbi.nlm.nih.gov)

                                  1 Reply Last reply
                                  0
                                  • JørgenVarnæsJ Offline
                                    JørgenVarnæsJ Offline
                                    JørgenVarnæs
                                    wrote on sidst redigeret af
                                    #722

                                    Perhaps news from FDA on Epco RR FL later tonight?

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #723

                                      Think PDUFA date is next Friday 28th of June. https://www.guidelinecentral.com/blog/june-2024-fda-pdufa-dates/

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #724

                                        Linket fra Winkels interview der ligger højere oppe i tråden er ganske interessant på flere punkter. 13:30 inde snakker han om samarbejdet med Biontech og at de har fundet en måde at påvirke immunsystemet på byond Ctla-4 (Ipilimumab) som giver en meget hurtig effekt på tumore. Vi har nu set Gen1046 resultater og at det ikke er det stof han henviser til i de kommentarer. Der kan potentielt være Gen1042 !

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #725

                                          https://vimeo.com/952351018/1f3353af8c?share=copy Link her

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper